This injectable compound is in preclinical development for the treatment of serious gram- positive infections. The company recently received a $9.3 million investment commitment from the Government of
The study will assess the efficacy of Neurodex in relieving pain in adult patients with distal symmetrical diabetic neuropathy with daily pain in the lower extremities. The clinical
Avanafil was compared to placebo in a study of 284 men with erectile dysfunction (ED). The most significant results were produced when the drug was administered at a
In a previous month-long phase II study, APD356 demonstrated a highly statistically significant average weight loss of 2.9 pounds in patients taking a 15mg dose of the drug.
The study is designed to evaluate the anti-tumor activity of talabostat in combination with gemcitabine in patients with metastatic pancreatic cancer. The trial design is a single-arm, two-stage
Preliminary results of a phase I clinical trial of CAT-354, a human anti-IL13 monoclonal antibody being studied as a potential treatment for severe asthma, showed CAT-354 to be
The FDA approved Aptivus (tipranavir) capsules, an HIV protease inhibitor, to be given with ritonavir for treatment of HIV-1 infected adults. Ritonavir is also a protease inhibitor; this
Pending FDA review and clearance, SciClone expects to initiate a phase I clinical trial of SCV-07 in healthy volunteers during the second half of 2005. SCV-07 is a
A second phase III trial in a younger adult population is scheduled to be conducted in Europe and Canada in early 2006. Assuming positive data from these trials,
The FDA accepted the filing the Sanofi’s new drug application for rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.